| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former Officer and Director | CEO & President
1 company
Mathew N Hulett last filed a Form 4 in April 2024, as Former Officer and Director at PETS. Mathew N Hulett's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 103,850 shares of PETS. Net of sales, the PETS filings show accumulation of 13,850 shares.
Mathew N Hulett has 2 Form 4 filings on record from November 2023 to April 2024, all as Former Officer and Director at Petmed Express (PETS), 2023–2024.
The 2 reported transactions were 1 disposition back to the company and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $101K and no sales.
The only open-market purchase was 13,850 shares of PETS at an average $7.26 on November 3, 2023, about $101K. Twelve months later PETS was down 42%.
Shares as reported in the last Form 4 for each company; the most recent is from April 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 | PETS Petmed Express Inc | CEO & President | Buy | 13,850 | $7.26 | $100,551.00 | +2.3% | -12.6% | -41.9% |